Clinical Trials Logo

Clinical Trial Summary

This is a prospective, single arm study, consisting of 20 women with abdominal surgical wound dehiscence that requires secondary closure. The participants will receive a weekly application of ActiGraft for 4 weeks, or until complete healing of the wound (the earlier of the two). An historic matched-control group of 20 patients will be compared retrospectively


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04899466
Study type Interventional
Source RedDress Ltd.
Contact Sharon Sirota
Phone +972545800765
Email sharon@reddress.co.il
Status Not yet recruiting
Phase N/A
Start date June 1, 2021
Completion date July 1, 2022